NOBL vs SCHD

Key Takeaways

• Different construction philosophies: NOBL is an equal-weighted index of S&P 500 companies with 25+ consecutive years of dividend growth, while SCHD is a market-cap-weighted portfolio of roughly 100 high-quality, high-yield U.S. dividend payers.
• Cost gap is significant: SCHD charges 0.06% versus NOBL's 0.35%, a structural advantage that compounds over long holding periods.
• Divergent sector exposure: NOBL tilts heavily toward consumer staples and industrials with minimal technology, while SCHD carries meaningful weight in healthcare, technology, and energy.
• Concentration differs sharply: NOBL's equal weighting keeps any single holding near 1.5–2%, whereas SCHD's top names each approach 4–5% of assets.
• Income profile favors SCHD: SCHD historically offers a higher dividend yield and faster payout growth, while NOBL emphasizes dividend longevity over yield.
• Risk and style profiles diverge: SCHD skews toward larger-cap value with lower volatility, while NOBL's equal weighting introduces a mid-cap and quality tilt.

Introduction

NOBL and SCHD are two of the most widely followed dividend exchange-traded funds (ETFs) in the U.S. market, yet they are often mistaken for direct substitutes. Both target income-oriented investors seeking durable cash flows and downside resilience, but they pursue that goal through fundamentally different index rules. Understanding how each fund screens, weights, and rebalances its holdings is essential for any investor building a dividend allocation. This ETF comparison examines structural differences, sector exposure, cost efficiency, fund performance, and relative positioning to clarify which strategy better suits distinct investor objectives in the current market environment.

ProShares S&P 500 Dividend Aristocrats ETF (NOBL) Overview

NOBL tracks the S&P 500 Dividend Aristocrats Index, which includes S&P 500 constituents that have increased their dividend payments every year for at least 25 consecutive years. This demanding screen produces a relatively compact portfolio of roughly 70 holdings. Critically, NOBL applies equal weighting, so each company carries a similar weight of about 1.5–2% regardless of market capitalization, and the index caps any single sector near 30% of the fund.

The fund's sector allocation reflects its longevity screen: consumer staples lead at roughly 23%, followed by industrials near 20%, financials around 13%, healthcare near 11%, and materials close to 10%. Technology is a minor component at roughly 4–5%. Representative top holdings have included names such as EMR, ADP, XOM, CVX, and CAT, each typically near 1.6–1.8% of assets. NOBL is a passively managed fund that carries a 0.35% expense ratio and rebalances on a scheduled basis to maintain equal weightings.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

SCHD tracks the Dow Jones U.S. Dividend 100 Index, which screens U.S. companies for dividend consistency, cash-flow strength, and fundamental quality before ranking the top 100 by indicated yield. The result is a portfolio of approximately 100–104 large-cap holdings weighted by market capitalization, with individual positions capped to limit concentration. SCHD is a passive, market-cap-weighted fund with an exceptionally low 0.06% expense ratio.

Sector exposure is broader and more yield-driven than NOBL's. Consumer staples lead at about 20%, followed by healthcare near 19%, technology around 16%, and energy near 16%, with financials, industrials, and consumer discretionary filling out the remainder. Top holdings have recently included TXN, QCOM, PG, CVX, KO, MRK, UNH, and VZ, each near 3.8–4.9% of the portfolio. SCHD rebalances quarterly and tends to carry a higher dividend yield than NOBL, historically around 3.5%.

Industry and Thematic Backdrop

Both funds sit at the intersection of several macro themes shaping dividend investing today. Elevated interest rates over recent cycles have increased competition for income strategies from money market funds and short-duration bonds, pressuring dividend equities to justify their risk. At the same time, a rotation toward value and defensive sectors has periodically favored the staples, healthcare, and energy names that dominate SCHD and, to a lesser extent, NOBL.

Regulatory and earnings-cycle dynamics also matter. Healthcare holdings face patent-cliff and drug-pricing scrutiny, while energy exposure is tied to commodity prices and capital-discipline trends among producers. NOBL's heavy industrials weighting makes it sensitive to manufacturing cycles and infrastructure spending, whereas its limited technology exposure means it has lagged during growth-led rallies. Persistent demand for income, low-volatility equity, and "quality dividend" strategies continues to support capital flows into both funds, though their distinct sector mixes mean they respond differently to the same macro forces.

Performance and Positioning Comparison

In recent market cycles, SCHD has generally benefited from its higher yield, lower cost, and larger average market capitalization, which have supported steadier relative positioning during defensive and value-led phases. Its meaningful energy and healthcare exposure has amplified returns when those sectors outperform, but it can also introduce concentration risk when a single industry stumbles.

NOBL, by contrast, has shown greater sensitivity to the performance of equal-weighted, mid-cap-leaning quality names. Its minimal technology allocation has caused it to trail broad benchmarks during growth-driven stretches, while its staples-and-industrials tilt has offered relative resilience in risk-off environments. Volatility profiles differ accordingly: NOBL's equal weighting can mute single-stock risk but leaves it more exposed to smaller-cap drawdowns, whereas SCHD's market-cap weighting concentrates returns in a handful of mega-cap dividend payers. Neither fund is leveraged or inverse; both are long-only equity strategies, making relative performance a function of sector rotation and dividend-style momentum rather than structural leverage.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, and breakout candidates far more efficiently than manual screening. For investors comparing income-oriented funds like NOBL and SCHD, it offers a data-driven way to assess relative momentum, sector strength, and risk before committing capital.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely lean toward SCHD in the current environment. Its 0.06% expense ratio is a decisive structural advantage over NOBL's 0.35%, and its higher dividend yield and larger-cap, lower-volatility profile tend to align with the risk preferences of income investors. SCHD's exposure to quality healthcare, technology, and energy franchises also provides diversification that NOBL's staples-and-industrials concentration lacks. That said, NOBL retains appeal for investors who prioritize 25-year dividend-growth streaks and pure equal-weight diversification. The outcome is probabilistic rather than absolute: SCHD appears favored on cost, yield, and trend consistency, while NOBL remains a defensible choice for longevity-focused, equal-weight exposure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations